Vladimir B. Arion

Overview

Best Publications

• Antitumour metal compounds: more than theme and variations.

  Michael A. Jakupec;Markus Galanski;Vladimir B. Arion;Christian G. Hartinger

  777
  Citations

• Recent Developments in the Field of Tumor-Inhibiting Metal Complexes

  M. Galanski;V. B. Arion;M. A. Jakupec;B. K. Keppler

  723
  Citations

• Template Synthesis of Macrocyclic Compounds

  Nicolai V. Gerbeleu;Vladimir B. Arion;John Burgess

  298
  Citations

• Electron-transfer activated metal-based anticancer drugs

  Erwin Reisner;Erwin Reisner;Vladimir B. Arion;Bernhard K. Keppler;Armando J.L. Pombeiro

  287
  Citations

• Transferrin binding and transferrin-mediated cellular uptake of the ruthenium coordination compound KP1019, studied by means of AAS, ESI-MS and CD spectroscopy

  Martina Pongratz;Petra Schluga;Michael A. Jakupec;Vladimir B. Arion

  282
  Citations

• Tuning of redox potentials for the design of ruthenium anticancer drugs: an Electrochemical study of [trans-RuCl4L(DMSO)]- and [trans-RuCl4L2]- complexes, where L = imidazole, 1,2,4-triazole, indazole

  Erwin Reisner;Vladimir B Arion;M Fátima C Guedes da Silva;Roman Lichtenecker

  239
  Citations

• Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation

  Christian R. Kowol;Robert Trondl;Petra Heffeter;Vladimir B. Arion

  221
  Citations

• Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activity.

  Michael Groessl;Erwin Reisner;Christian G. Hartinger;Rene Eichinger

  213
  Citations

• Redox-Active Antineoplastic Ruthenium Complexes with Indazole: Correlation of in Vitro Potency and Reduction Potential

  Michael A. Jakupec;Erwin Reisner;Anna Eichinger;Martina Pongratz

  207
  Citations

• Gallium(III) and Iron(III) Complexes of α-N-Heterocyclic Thiosemicarbazones: Synthesis, Characterization, Cytotoxicity, and Interaction with Ribonucleotide Reductase

  Christian R. Kowol;Roland Berger;Rene Eichinger;Alexander Roller

  206
  Citations

• Highly Antiproliferative Ruthenium(II) and Osmium(II) Arene Complexes with Paullone-Derived Ligands

  Wolfgang F. Schmid;Roland O. John;Vladimir B. Arion;Michael A. Jakupec

  198
  Citations

• Structure–Activity Relationships of Targeted RuII(η6-p-Cymene) Anticancer Complexes with Flavonol-Derived Ligands

  Andrea Kurzwernhart;Wolfgang Kandioller;Simone Bächler;Caroline Bartel

  162
  Citations

• Targeting the DNA-topoisomerase complex in a double-strike approach with a topoisomerase inhibiting moiety and covalent DNA binder

  Andrea Kurzwernhart;Wolfgang Kandioller;Caroline Bartel;Simone Bächler

  157
  Citations

• Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): A combined experimental and theoretical study

  Ana Popović-Bijelić;Christian R. Kowol;Maria E.S. Lind;Jinghui Luo

  154
  Citations

• Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteins.

  Alexander V. Rudnev;Lidia S. Foteeva;Christian Kowol;Roland Berger

  149
  Citations

• A SAR Study of Novel Antiproliferative Ruthenium and Osmium Complexes with Quinoxalinone Ligands in Human Cancer Cell Lines

  Werner Ginzinger;Gerhard Mühlgassner;Vladimir B. Arion;Michael A. Jakupec

  146
  Citations

• Synthesis, structure, spectroscopic and in vitro antitumour studies of a novel gallium(III) complex with 2-acetylpyridine 4N-dimethylthiosemicarbazone

  Vladimir B. Arion;Michael A. Jakupec;Markus Galanski;Peter Unfried

  144
  Citations

• Novel metal(II) arene 2-pyridinecarbothioamides: a rationale to orally active organometallic anticancer agents

  Samuel M. Meier;Muhammad Hanif;Muhammad Hanif;Zenita Adhireksan;Verena Pichler

  144
  Citations

• In vitro anticancer activity and biologically relevant metabolization of organometallic ruthenium complexes with carbohydrate-based ligands.

  Isabella Berger;Muhammad Hanif;Alexey A. Nazarov;Alexey A. Nazarov;Christian G. Hartinger;Christian G. Hartinger

  143
  Citations

• Molecular Engineering of Benzothiazolium Salts with Large Quadratic Hyperpolarizabilities: Can Auxiliary Electron-Withdrawing Groups Enhance Nonlinear Optical Responses?

  Peter Hrobárik;Ivica Sigmundová;Pavol Zahradník;Peter Kasák

  139
  Citations

• Maltol‐Derived Ruthenium–Cymene Complexes with Tumor Inhibiting Properties: The Impact of Ligand–Metal Bond Stability on Anticancer Activity In Vitro

  Wolfgang Kandioller;Christian G. Hartinger;Alexey A. Nazarov;Alexey A. Nazarov;Caroline Bartel

  135
  Citations